|
The written collaborative agreement shall
be for
services the |
collaborating physician generally provides to
his or her |
patients in the normal course of clinical medical practice.
A |
written collaborative agreement shall be adequate with respect |
to collaboration
with advanced practice nurses if all of the |
following apply:
|
(1) The agreement is written to promote the exercise of |
professional judgment by the advanced practice nurse |
commensurate with his or her education and experience. The |
agreement need not describe the exact steps that an |
advanced practice nurse must take with respect to each |
specific condition, disease, or symptom, but must specify |
those procedures that require a physician's presence as the |
procedures are being performed.
|
(2) Practice guidelines and orders are developed and |
approved jointly by the advanced practice nurse and |
collaborating physician, as needed, based on the practice |
of the practitioners. Such guidelines and orders and the |
patient services provided thereunder are periodically |
reviewed by the collaborating physician.
|
(3) The advance practice nurse provides services the |
collaborating physician generally provides to his or her |
patients in the normal course of clinical practice, except |
as set forth in subsection (b-5) of this Section. With |
respect to labor and delivery, the collaborating physician |
must provide delivery services in order to participate with |
|
a certified nurse midwife. |
(4) The collaborating physician and advanced practice |
nurse consult meet in person at least once a month to |
provide collaboration and consultation. |
(5) Methods of communication are available with the |
collaborating physician in person or through |
telecommunications for consultation, collaboration, and |
referral as needed to address patient care needs. |
(6) The agreement contains provisions detailing notice |
for termination or change of status involving a written |
collaborative agreement, except when such notice is given |
for just cause.
|
(b-5) An anesthesiologist or physician licensed to |
practice medicine in
all its branches may collaborate with a |
certified registered nurse anesthetist
in accordance with |
Section 65-35 of the Nurse Practice Act for the provision of |
anesthesia services. With respect to the provision of |
anesthesia services, the collaborating anesthesiologist or |
physician shall have training and experience in the delivery of |
anesthesia services consistent with Department rules. |
Collaboration shall be
adequate if:
|
(1) an anesthesiologist or a physician
participates in |
the joint formulation and joint approval of orders or
|
guidelines and periodically reviews such orders and the |
services provided
patients under such orders; and
|
(2) for anesthesia services, the anesthesiologist
or |
|
physician participates through discussion of and agreement |
with the
anesthesia plan and is physically present and |
available on the premises during
the delivery of anesthesia |
services for
diagnosis, consultation, and treatment of |
emergency medical conditions.
Anesthesia services in a |
hospital shall be conducted in accordance with
Section 10.7 |
of the Hospital Licensing Act and in an ambulatory surgical
|
treatment center in accordance with Section 6.5 of the |
Ambulatory Surgical
Treatment Center Act.
|
(b-10) The anesthesiologist or operating physician must |
agree with the
anesthesia plan prior to the delivery of |
services.
|
(c) The supervising physician shall have access to the
|
medical records of all patients attended by a physician
|
assistant. The collaborating physician shall have access to
the |
medical records of all patients attended to by an
advanced |
practice nurse.
|
(d) (Blank).
|
(e) A physician shall not be liable for the acts or
|
omissions of a physician assistant or advanced practice
nurse |
solely on the basis of having signed a
supervision agreement or |
guidelines or a collaborative
agreement, an order, a standing |
medical order, a
standing delegation order, or other order or |
guideline
authorizing a physician assistant or advanced |
practice
nurse to perform acts, unless the physician has
reason |
to believe the physician assistant or advanced
practice nurse |
|
lacked the competency to perform
the act or acts or commits |
willful and wanton misconduct.
|
(f) A collaborating physician may, but is not required to, |
delegate prescriptive authority to an advanced practice nurse |
as part of a written collaborative agreement, and the |
delegation of prescriptive authority shall conform to the |
requirements of Section 65-40 of the Nurse Practice Act. |
(g) A supervising physician may, but is not required to, |
delegate prescriptive authority to a physician assistant as |
part of a written supervision agreement, and the delegation of |
prescriptive authority shall conform to the requirements of |
Section 7.5 of the Physician Assistant Practice Act of 1987. |
(Source: P.A. 95-639, eff. 10-5-07; 96-618, eff. 1-1-10 .)
|
Section 10. The Nurse Practice Act is amended by changing |
Sections 65-35, 65-40, and 65-45 as follows:
|
(225 ILCS 65/65-35)
(was 225 ILCS 65/15-15)
|
(Section scheduled to be repealed on January 1, 2018)
|
Sec. 65-35. Written collaborative
agreements. |
(a) A written collaborative agreement is required for all |
advanced practice nurses engaged in clinical practice, except |
for advanced practice nurses who are authorized to practice in |
a hospital or ambulatory surgical treatment center. |
(a-5) If an advanced practice nurse engages in clinical |
practice outside of a hospital or ambulatory surgical treatment |
|
center in which he or she is authorized to practice, the |
advanced practice nurse must have a written collaborative |
agreement.
|
(b) A written collaborative
agreement shall describe the |
working relationship of the
advanced practice nurse with the |
collaborating
physician or podiatrist and shall authorize the |
categories of
care, treatment, or procedures to be performed by |
the advanced
practice nurse. A collaborative agreement with a |
dentist must be in accordance with subsection (c-10) of this |
Section. Collaboration does not require an
employment |
relationship between the collaborating physician
and advanced |
practice nurse. Absent an employment relationship, an |
agreement may not restrict the categories of patients or |
third-party payment sources accepted by the advanced practice |
nurse. Collaboration means
the relationship under
which an |
advanced practice nurse works with a collaborating
physician or |
podiatrist in an active clinical practice to deliver health |
care services in
accordance with
(i) the advanced practice |
nurse's training, education,
and experience and (ii) |
collaboration and consultation as documented in a
jointly |
developed written collaborative
agreement.
|
The agreement shall be defined to promote the
exercise of |
professional judgment by the advanced practice
nurse |
commensurate with his or her education and
experience. The |
services to be provided by the advanced
practice nurse shall be |
services that the
collaborating physician or podiatrist is |
|
authorized to and generally provides to his or her
patients in |
the normal course of his or her clinical medical practice, |
except as set forth in subsection (c-5) of this Section.
The |
agreement need not describe the exact steps that an advanced |
practice
nurse must take with respect to each specific |
condition, disease, or symptom
but must specify
which |
authorized procedures require the presence of the |
collaborating physician or podiatrist as
the procedures are |
being performed. The collaborative
relationship under an |
agreement shall not be
construed to require the personal |
presence of a physician or podiatrist at
all times at the place |
where services are rendered.
Methods of communication shall
be |
available for consultation with the collaborating
physician or |
podiatrist in person or by telecommunications in accordance |
with
established written guidelines as set forth in the written
|
agreement.
|
(c) Collaboration and consultation under all collaboration |
agreements
shall be adequate if a
collaborating physician or |
podiatrist does each of the following:
|
(1) Participates in the joint formulation and joint |
approval of orders or
guidelines with the advanced practice |
nurse and he or she periodically reviews such orders and |
the
services provided patients under such orders in |
accordance with accepted
standards of medical practice or |
podiatric practice and advanced practice nursing practice.
|
(2) Provides collaboration and consultation Meets in |
|
person with the advanced practice nurse at least once a |
month to provide collaboration and
consultation . In the |
case of anesthesia services provided by a certified |
registered nurse anesthetist, an anesthesiologist, |
physician, dentist, or podiatrist must participate through |
discussion of and agreement with the anesthesia plan and |
remain physically present and available on the premises |
during the delivery of anesthesia services for diagnosis, |
consultation, and treatment of emergency medical |
conditions.
|
(3) Is available through telecommunications for |
consultation on medical
problems, complications, or |
emergencies or patient referral. In the case of anesthesia |
services provided by a certified registered nurse |
anesthetist, an anesthesiologist, physician, dentist, or |
podiatrist must participate through discussion of and |
agreement with the anesthesia plan and remain physically |
present and available on the premises during the delivery |
of anesthesia services for diagnosis, consultation, and |
treatment of emergency medical conditions.
|
The agreement must contain provisions detailing notice for |
termination or change of status involving a written |
collaborative agreement, except when such notice is given for |
just cause. |
(c-5) A certified registered nurse anesthetist, who |
provides anesthesia services outside of a hospital or |
|
ambulatory surgical treatment center shall enter into a written |
collaborative agreement with an anesthesiologist or the |
physician licensed to practice medicine in all its branches or |
the podiatrist performing the procedure. Outside of a hospital |
or ambulatory surgical treatment center, the certified |
registered nurse anesthetist may provide only those services |
that the collaborating podiatrist is authorized to provide |
pursuant to the Podiatric Medical Practice Act of 1987 and |
rules adopted thereunder. A certified registered nurse |
anesthetist may select, order, and administer medication, |
including controlled substances, and apply appropriate medical |
devices for delivery of anesthesia services under the |
anesthesia plan agreed with by the anesthesiologist or the |
operating physician or operating podiatrist. |
(c-10) A certified registered nurse anesthetist who |
provides anesthesia services in a dental office shall enter |
into a written collaborative agreement with an |
anesthesiologist or the physician licensed to practice |
medicine in all its branches or the operating dentist |
performing the procedure. The agreement shall describe the |
working relationship of the certified registered nurse |
anesthetist and dentist and shall authorize the categories of |
care, treatment, or procedures to be performed by the certified |
registered nurse anesthetist. In a collaborating dentist's |
office, the certified registered nurse anesthetist may only |
provide those services that the operating dentist with the |
|
appropriate permit is authorized to provide pursuant to the |
Illinois Dental Practice Act and rules adopted thereunder. For |
anesthesia services, an anesthesiologist, physician, or |
operating dentist shall participate through discussion of and |
agreement with the anesthesia plan and shall remain physically |
present and be available on the premises during the delivery of |
anesthesia services for diagnosis, consultation, and treatment |
of emergency medical conditions. A certified registered nurse |
anesthetist may select, order, and administer medication, |
including controlled substances, and apply appropriate medical |
devices for delivery of anesthesia services under the |
anesthesia plan agreed with by the operating dentist. |
(d) A copy of the signed, written collaborative agreement |
must be available
to the Department upon request from both the |
advanced practice nurse
and the collaborating physician or |
podiatrist. |
(e) Nothing in this Act shall be construed to limit the |
delegation of tasks or duties by a physician to a licensed |
practical nurse, a registered professional nurse, or other |
persons in accordance with Section 54.2 of the Medical Practice |
Act of 1987. Nothing in this Act shall be construed to limit |
the method of delegation that may be authorized by any means, |
including, but not limited to, oral, written, electronic, |
standing orders, protocols, guidelines, or verbal orders. |
(f) An advanced
practice nurse shall inform each |
collaborating physician, dentist, or podiatrist of all |
|
collaborative
agreements he or she
has signed and provide a |
copy of these to any collaborating physician, dentist, or |
podiatrist upon
request.
|
(g) For the purposes of this Act, "generally provides to |
his or her patients in the normal course of his or her clinical |
medical practice" means services, not specific tasks or duties, |
the physician or podiatrist routinely provides individually or |
through delegation to other persons so that the physician or |
podiatrist has the experience and ability to provide |
collaboration and consultation. |
(Source: P.A. 95-639, eff. 10-5-07; 96-618, eff. 1-1-10.)
|
(225 ILCS 65/65-40)
(was 225 ILCS 65/15-20)
|
(Section scheduled to be repealed on January 1, 2018)
|
Sec. 65-40. Written collaborative agreement; prescriptive |
Prescriptive authority.
|
(a) A collaborating
physician or podiatrist may, but is not |
required to, delegate
prescriptive authority to an advanced |
practice
nurse as part of a written collaborative agreement. |
This authority may, but is
not required to, include
|
prescription of, selection of, orders for, administration of, |
storage of, acceptance of samples of, and dispensing over the |
counter medications, legend drugs, medical gases, and |
controlled
substances categorized as
any Schedule III through V |
controlled substances, as defined in Article II of the
Illinois |
Controlled Substances Act, and other preparations, including, |
|
but not limited to, botanical and herbal remedies. The |
collaborating physician or podiatrist must have a valid current |
Illinois controlled substance license and federal registration |
to delegate authority to prescribe delegated controlled |
substances.
|
(b) To prescribe controlled
substances under this Section, |
an advanced practice
nurse must obtain a mid-level practitioner |
controlled substance license.
Medication orders shall be
|
reviewed
periodically by the collaborating physician or |
podiatrist.
|
(c) The collaborating physician or podiatrist shall file |
with the
Department notice of delegation of prescriptive |
authority
and
termination of such delegation, in accordance |
with rules of the Department.
Upon receipt of this notice |
delegating authority to prescribe any Schedule III through V |
controlled substances, the licensed advanced practice nurse |
shall be
eligible to register for a mid-level practitioner |
controlled substance license
under Section 303.05 of the |
Illinois Controlled Substances Act.
|
(d) In addition to the requirements of subsections (a), |
(b), and (c) of this Section, a collaborating physician or |
podiatrist may, but is not required to, delegate authority to |
an advanced practice nurse to prescribe any Schedule II |
controlled substances, if all of the following conditions |
apply: |
(1) Specific No more than 5 Schedule II controlled |
|
substances by oral dosage or topical or transdermal |
application may be delegated , provided that the delegated |
Schedule II controlled substances are routinely prescribed |
by the collaborating physician or podiatrist. This |
delegation must identify the specific Schedule II |
controlled substances by either brand name or generic name . |
Schedule II controlled substances to be delivered by |
injection or other route of administration may not be |
delegated. |
(2) Any delegation must be controlled substances that |
the collaborating physician or podiatrist prescribes. |
(3) Any prescription must be limited to no more than a |
30-day supply oral dosage , with any continuation |
authorized only after prior approval of the collaborating |
physician or podiatrist . |
(4) The advanced practice nurse must discuss the |
condition of any patients for whom a controlled substance |
is prescribed monthly with the delegating physician. |
(5) The advanced practice nurse meets the education |
requirements of Section 303.05 of the Illinois Controlled |
Substances Act.
|
(e) Nothing in this Act shall be construed to limit the |
delegation of tasks
or duties by a physician to a licensed |
practical nurse, a registered
professional nurse, or other |
persons. Nothing in this Act shall be construed to limit the |
method of delegation that may be authorized by any means, |
|
including, but not limited to, oral, written, electronic, |
standing orders, protocols, guidelines, or verbal orders.
|
(f) Nothing in this Section shall be construed to apply to |
any medication authority including Schedule II controlled |
substances of an advanced practice nurse for care provided in a |
hospital, hospital affiliate, or ambulatory surgical treatment |
center pursuant to Section 65-45. |
(g) Any advanced practice nurse who writes a prescription |
for a controlled substance without having a valid appropriate |
authority may be fined by the Department not more than $50 per |
prescription, and the Department may take any other |
disciplinary action provided for in this Act. |
(h) Nothing in this Section shall be construed to prohibit |
generic substitution. |
(Source: P.A. 95-639, eff. 10-5-07; 96-189, eff. 8-10-09.)
|
(225 ILCS 65/65-45)
(was 225 ILCS 65/15-25)
|
(Section scheduled to be repealed on January 1, 2018)
|
Sec. 65-45. Advanced practice nursing in hospitals , |
hospital affiliates, or ambulatory surgical treatment centers.
|
(a) An advanced practice nurse may provide
services in a |
licensed hospital or a hospital affiliate as those terms are |
defined in the Hospital Licensing Act or the University of |
Illinois Hospital Act or a licensed ambulatory surgical
|
treatment center without prescriptive authority or a written |
collaborative agreement pursuant to Section 65-35 of this Act. |
|
An advanced practice nurse must possess clinical privileges |
recommended by the hospital medical staff and granted by the |
hospital or the consulting medical staff committee and |
ambulatory surgical treatment center in order to provide |
services. The medical staff or consulting medical staff |
committee shall periodically review the services of advanced |
practice nurses granted clinical privileges , including any |
care provided in a hospital affiliate . Authority may also be |
granted when recommended by the hospital medical staff and |
granted by the hospital or recommended by the consulting |
medical staff committee and ambulatory surgical treatment |
center to individual advanced practice nurses to select, order, |
and administer medications, including controlled substances, |
to provide delineated care. In a hospital, hospital affiliate, |
or ambulatory surgical treatment center, the The attending |
physician shall determine an advanced practice nurse's role in |
providing care for his or her patients, except as otherwise |
provided in the medical staff bylaws or consulting committee |
policies.
|
(a-2) An advanced practice nurse granted authority to order |
medications including controlled substances may complete |
discharge prescriptions provided the prescription is in the |
name of the advanced practice nurse and the attending or |
discharging physician. |
(a-3) Advanced practice nurses practicing in a hospital or |
an ambulatory surgical treatment center are not required to |
|
obtain a mid-level controlled substance license to order |
controlled substances under Section 303.05 of the Illinois |
Controlled Substances Act. |
(a-5) For
anesthesia services provided by a certified |
registered nurse anesthetist, an anesthesiologist,
physician, |
dentist,
or podiatrist shall participate through discussion of |
and agreement with the
anesthesia plan and shall
remain
|
physically present
and be available on the premises during the |
delivery of anesthesia services for
diagnosis, consultation, |
and treatment of
emergency medical conditions, unless hospital |
policy adopted pursuant to
clause (B) of subdivision (3) of |
Section 10.7 of the Hospital Licensing Act
or ambulatory |
surgical treatment center policy adopted pursuant to
clause (B) |
of subdivision (3) of Section 6.5 of the Ambulatory Surgical
|
Treatment Center Act
provides otherwise. A certified |
registered nurse anesthetist may select, order, and administer |
medication for anesthesia services under the anesthesia plan |
agreed to by the anesthesiologist or the physician, in |
accordance with hospital alternative policy or the medical |
staff consulting committee policies of a licensed ambulatory |
surgical treatment center.
|
(b) An advanced practice nurse who provides
services in a |
hospital shall do so in accordance with Section 10.7 of the
|
Hospital
Licensing Act and, in an
ambulatory surgical treatment |
center, in accordance with Section 6.5 of the
Ambulatory
|
Surgical Treatment Center Act.
|
|
(Source: P.A. 95-639, eff. 10-5-07.)
|
Section 15. The Physician Assistant Practice Act of 1987 is |
amended by changing Section 7.5 as follows:
|
(225 ILCS 95/7.5)
|
(Section scheduled to be repealed on January 1, 2018)
|
Sec. 7.5. Prescriptions; written supervision agreements; |
prescriptive authority. |
(a) A written supervision agreement is required for all |
physician assistants to practice in the State. |
(1) A written supervision agreement shall describe the |
working relationship of the physician assistant with the |
supervising physician and shall authorize the categories |
of care, treatment, or procedures to be performed by the |
physician assistant.
The written supervision agreement |
shall be defined to promote the exercise of professional |
judgment by the physician assistant commensurate with his |
or her education and experience. The services to be |
provided by the physician assistant shall be services that |
the supervising physician is authorized to and generally |
provides to his or her patients in the normal course of his |
or her clinical medical practice. The written supervision |
agreement need not describe the exact steps that a |
physician assistant must take with respect to each specific |
condition, disease, or symptom but must specify which |
|
authorized procedures require the presence of the |
supervising physician as the procedures are being |
performed. The supervision relationship under a written |
supervision agreement shall not be construed to require the |
personal presence of a physician at all times at the place |
where services are rendered. Methods of communication |
shall be available for consultation with the supervising |
physician in person or by telecommunications in accordance |
with established written guidelines as set forth in the |
written supervision agreement. For the purposes of this |
Act, "generally provides to his or her patients in the |
normal course of his or her clinical medical practice" |
means services, not specific tasks or duties, the |
supervising physician routinely provides individually or |
through delegation to other persons so that the physician |
has the experience and ability to provide supervision and |
consultation. |
(2) The written supervision agreement shall be |
adequate if a physician does each of the following: |
(A) Participates in the joint formulation and |
joint approval of orders or guidelines with the |
physician assistant and he or she periodically reviews |
such orders and the services provided patients under |
such orders in accordance with accepted standards of |
medical practice and physician assistant practice. |
(B) Provides supervision and consultation Meets in |
|
person with the physician assistant at least once a |
month to provide supervision . |
(3) A copy of the signed, written supervision agreement |
must be available to the Department upon request from both |
the physician assistant and the supervising physician. |
(4) A physician assistant shall inform each |
supervising physician of all written supervision |
agreements he or she has signed and provide a copy of these |
to any supervising physician upon request. |
(b) A supervising physician may, but is not required to, |
delegate prescriptive authority to a physician assistant as |
part of a written supervision agreement. This authority may, |
but is not required to, include prescription of, selection of, |
orders for, administration of, storage of, acceptance of |
samples of, and dispensing over the counter medications, legend |
drugs, medical gases, and controlled substances categorized as |
Schedule III through V controlled substances, as defined in |
Article II of the Illinois Controlled Substances Act, and other |
preparations, including, but not limited to, botanical and |
herbal remedies. The supervising physician must have a valid, |
current Illinois controlled substance license and federal |
registration with the Drug Enforcement Agency to delegate the |
authority to prescribe controlled substances. |
(1) To prescribe Schedule III, IV, or V controlled |
substances under this
Section, a physician assistant must |
obtain a mid-level practitioner
controlled substances |
|
license. Medication orders issued by a
physician
assistant |
shall be reviewed
periodically by the supervising |
physician. |
(2) The supervising physician shall file
with the |
Department notice of delegation of prescriptive authority |
to a
physician assistant and
termination of delegation, |
specifying the authority delegated or terminated.
Upon |
receipt of this notice delegating authority to prescribe |
Schedule III,
IV, or V controlled substances, the physician |
assistant shall be eligible to
register for a mid-level |
practitioner controlled substances license under
Section |
303.05 of the Illinois Controlled Substances Act.
Nothing |
in this Act shall be construed to limit the delegation of |
tasks or
duties by the supervising physician to a nurse or |
other appropriately trained
persons in accordance with |
Section 54.2 of the Medical Practice Act of 1987.
|
(3) In addition to the requirements of subsection (b) |
of this Section, a supervising physician may, but is not |
required to, delegate authority to a physician assistant to |
prescribe Schedule II controlled substances, if all of the |
following conditions apply: |
(A) Specific No more than 5 Schedule II controlled |
substances by oral dosage or topical or transdermal |
application may be delegated , provided that the |
delegated Schedule II controlled substances are |
routinely prescribed by the supervising physician. |
|
This delegation must identify the specific Schedule II |
controlled substances by either brand name or generic |
name . Schedule II controlled substances to be |
delivered by injection or other route of |
administration may not be delegated. |
(B) Any delegation must be controlled substances |
that the supervising physician prescribes. |
(C) Any prescription must be limited to no more |
than a 30-day supply oral dosage , with any continuation |
authorized only after prior approval of the |
supervising physician. |
(D) The physician assistant must discuss the |
condition of any patients for whom a controlled |
substance is prescribed monthly with the supervising |
physician. |
(E) The physician assistant meets the education |
requirements of Section 303.05 of the Illinois |
Controlled Substances Act. |
(c) Nothing in this Act shall be construed to limit the |
delegation of tasks or duties by a physician to a licensed |
practical nurse, a registered professional nurse, or other |
persons. Nothing in this Act shall be construed to limit the |
method of delegation that may be authorized by any means, |
including, but not limited to, oral, written, electronic, |
standing orders, protocols, guidelines, or verbal orders.
|
(d) Any physician assistant who writes a prescription for a |
|
controlled substance without having a valid appropriate |
authority may be fined by the Department not more than $50 per |
prescription, and the Department may take any other |
disciplinary action provided for in this Act. |
(e) Nothing in this Section shall be construed to prohibit |
generic substitution. |
(Source: P.A. 96-268, eff. 8-11-09; 96-618, eff. 1-1-10; |
96-1000, eff. 7-2-10.)
|
Section 20. The Podiatric Medical Practice Act of 1987 is |
amended by changing Section 20.5 as follows: |
(225 ILCS 100/20.5) |
(Section scheduled to be repealed on January 1, 2018)
|
Sec. 20.5. Delegation of authority to advanced practice |
nurses.
|
(a) A podiatrist in active clinical practice may |
collaborate with an advanced practice nurse in accordance with |
the requirements of the Nurse Practice Act. Collaboration shall |
be for the purpose of providing podiatric consultation and no |
employment relationship shall be required. A written |
collaborative agreement shall conform to the requirements of |
Section 65-35 of the Nurse Practice Act. The written |
collaborative agreement shall be for services the |
collaborating podiatrist generally provides to his or her |
patients in the normal course of clinical podiatric practice, |
|
except as set forth in item (3) of this subsection (a). A |
written collaborative agreement and podiatric collaboration |
and consultation shall be adequate with respect to advanced |
practice nurses if all of the following apply: |
(1) The agreement is written to promote the exercise of |
professional judgment by the advanced practice nurse |
commensurate with his or her education and experience. The |
agreement need not describe the exact steps that an |
advanced practice nurse must take with respect to each |
specific condition, disease, or symptom, but must specify |
which procedures require a podiatrist's presence as the |
procedures are being performed. |
(2) Practice guidelines and orders are developed and |
approved jointly by the advanced practice nurse and |
collaborating podiatrist, as needed, based on the practice |
of the practitioners. Such guidelines and orders and the |
patient services provided thereunder are periodically |
reviewed by the collaborating podiatrist. |
(3) The advance practice nurse provides services that |
the collaborating podiatrist generally provides to his or |
her patients in the normal course of clinical practice. |
With respect to the provision of anesthesia services by a |
certified registered nurse anesthetist, the collaborating |
podiatrist must have training and experience in the |
delivery of anesthesia consistent with Department rules. |
(4) The collaborating podiatrist and the advanced |
|
practice nurse consult meet in person at least once a month |
to provide collaboration and consultation. |
(5) Methods of communication are available with the |
collaborating podiatrist in person or through |
telecommunications for consultation, collaboration, and |
referral as needed to address patient care needs. |
(6) With respect to the provision of anesthesia |
services by a certified registered nurse anesthetist, an |
anesthesiologist, physician, or podiatrist shall |
participate through discussion of and agreement with the |
anesthesia plan and shall remain physically present and be |
available on the premises during the delivery of anesthesia |
services for diagnosis, consultation, and treatment of |
emergency medical conditions. The anesthesiologist or |
operating podiatrist must agree with the anesthesia plan |
prior to the delivery of services. |
(7) The agreement contains provisions detailing notice |
for termination or change of status involving a written |
collaborative agreement, except when such notice is given |
for just cause. |
(b) The collaborating podiatrist shall have access to the |
records of all patients attended to by an advanced practice |
nurse. |
(c) Nothing in this Section shall be construed to limit the |
delegation of tasks or duties by a podiatrist to a licensed |
practical nurse, a registered professional nurse, or other |
|
appropriately trained persons. |
(d) A podiatrist shall not be liable for the acts or |
omissions of an advanced practice nurse solely on the basis of |
having signed guidelines or a collaborative agreement, an |
order, a standing order, a standing delegation order, or other |
order or guideline authorizing an advanced practice nurse to |
perform acts, unless the podiatrist has reason to believe the |
advanced practice nurse lacked the competency to perform the |
act or acts or commits willful or wanton misconduct.
|
(f) A podiatrist, may, but is not required to delegate |
prescriptive authority to an advanced practice nurse as part of |
a written collaborative agreement and the delegation of |
prescriptive authority shall conform to the requirements of |
Section 65-40 of the Nurse Practice Act. |
(Source: P.A. 95-639, eff. 10-5-07; 96-618, eff. 1-1-10.) |
Section 25. The Illinois Controlled Substances Act is |
amended by changing Section 303.05 as follows:
|
(720 ILCS 570/303.05)
|
Sec. 303.05. Mid-level practitioner registration.
|
(a) The Department of Financial and Professional |
Regulation shall register licensed
physician assistants and |
licensed advanced practice nurses to prescribe and
dispense |
controlled substances under Section 303 and euthanasia
|
agencies to purchase, store, or administer animal euthanasia |
|
drugs under the
following circumstances:
|
(1) with respect to physician assistants,
|
(A) the physician assistant has been
delegated
|
authority to prescribe any Schedule III through V |
controlled substances by a physician licensed to |
practice medicine in all its
branches in accordance |
with Section 7.5 of the Physician Assistant Practice |
Act
of 1987;
and
the physician assistant has
completed |
the
appropriate application forms and has paid the |
required fees as set by rule;
or
|
(B) the physician assistant has been delegated
|
authority by a supervising physician licensed to |
practice medicine in all its branches to prescribe or |
dispense Schedule II controlled substances through a |
written delegation of authority and under the |
following conditions: |
(i) Specific no more than 5 Schedule II |
controlled substances by oral dosage or topical or |
transdermal application may be delegated , provided |
that the delegated Schedule II controlled |
substances are routinely prescribed by the |
supervising physician. This delegation must |
identify the specific Schedule II controlled |
substances by either brand name or generic name. |
Schedule II controlled substances to be delivered |
by injection or other route of administration may |
|
not be delegated ; |
(ii) any delegation must be of controlled |
substances prescribed by the supervising |
physician; |
(iii) all prescriptions must be limited to no |
more than a 30-day supply oral dosage , with any |
continuation authorized only after prior approval |
of the supervising physician; |
(iv) the physician assistant must discuss the |
condition of any patients for whom a controlled |
substance is prescribed monthly with the |
delegating physician; and |
(v) the physician assistant must have |
completed the appropriate application forms and |
paid the required fees as set by rule; |
(vi) the physician assistant must provide |
evidence of satisfactory completion of 45 contact |
hours in pharmacology from any physician assistant |
program accredited by the Accreditation Review |
Commission on Education for the Physician |
Assistant (ARC-PA), or its predecessor agency, for |
any new license issued with Schedule II authority |
after the effective date of this amendatory Act of |
the 97th General Assembly; and |
(vii) the physician assistant must annually |
complete at least 5 hours of continuing education |
|
in pharmacology. |
(2) with respect to advanced practice nurses, |
(A) the advanced practice nurse has been delegated
|
authority to prescribe any Schedule III through V |
controlled substances by a collaborating physician |
licensed to practice medicine in all its branches or a |
collaborating podiatrist in accordance with Section |
65-40 of the Nurse Practice
Act. The advanced practice |
nurse has completed the
appropriate application forms |
and has paid the required
fees as set by rule; or |
(B) the advanced practice nurse has been delegated
|
authority by a collaborating physician licensed to |
practice medicine in all its branches or collaborating |
podiatrist to prescribe or dispense Schedule II |
controlled substances through a written delegation of |
authority and under the following conditions: |
(i) specific no more than 5 Schedule II |
controlled substances by oral dosage or topical or |
transdermal application may be delegated , provided |
that the delegated Schedule II controlled |
substances are routinely prescribed by the |
collaborating physician or podiatrist. This |
delegation must identify the specific Schedule II |
controlled substances by either brand name or |
generic name. Schedule II controlled substances to |
be delivered by injection or other route of |
|
administration may not be delegated ; |
(ii) any delegation must be of controlled |
substances prescribed by the collaborating |
physician or podiatrist ; |
(iii) all prescriptions must be limited to no |
more than a 30-day supply oral dosage , with any |
continuation authorized only after prior approval |
of the collaborating physician or podiatrist ; |
(iv) the advanced practice nurse must discuss |
the condition of any patients for whom a controlled |
substance is prescribed monthly with the |
delegating physician or podiatrist ; and |
(v) the advanced practice nurse must have |
completed the appropriate application forms and |
paid the required fees as set by rule; or |
(vi) the advanced practice nurse must provide |
evidence of satisfactory completion of at least 45 |
graduate contact hours in pharmacology for any new |
license issued with Schedule II authority after |
the effective date of this amendatory Act of the |
97th General Assembly; and |
(vii) the advanced practice nurse must |
annually complete 5 hours of continuing education |
in pharmacology; or |
(3) with respect to animal euthanasia agencies, the |
euthanasia agency has
obtained a license from the |
|
Department of
Professional Regulation and obtained a |
registration number from the
Department.
|
(b) The mid-level practitioner shall only be licensed to |
prescribe those
schedules of controlled substances for which a |
licensed physician or licensed podiatrist has delegated
|
prescriptive authority, except that an animal euthanasia |
agency does not have any
prescriptive authority.
A physician |
assistant and an advanced practice nurse are prohibited from |
prescribing medications and controlled substances not set |
forth in the required written delegation of authority.
|
(c) Upon completion of all registration requirements, |
physician
assistants, advanced practice nurses, and animal |
euthanasia agencies shall be issued a
mid-level practitioner
|
controlled substances license for Illinois.
|
(d) A collaborating physician or podiatrist may, but is not |
required to, delegate prescriptive authority to an advanced |
practice nurse as part of a written collaborative agreement, |
and the delegation of prescriptive authority shall conform to |
the requirements of Section 65-40 of the Nurse Practice Act. |
(e) A supervising physician may, but is not required to, |
delegate prescriptive authority to a physician assistant as |
part of a written supervision agreement, and the delegation of |
prescriptive authority shall conform to the requirements of |
Section 7.5 of the Physician Assistant Practice Act of 1987. |
(f) Nothing in this Section shall be construed to prohibit |
generic substitution. |